News & insights

Covid-19

Moderna's Patent Pledge

While many think the Covid-19 is something from the past, it’s far from that in patent courts. A fierce battle on the technology behind the vaccines is going on.

Covid-19

COVID-19 vaccines – the post-pandemic fight continues

Moderna proves it’s still in the running as a major player in the mRNA vaccine IP landscape after the European Patent Office (EPO) maintains the validity of one of its key patents.

Covid-19

Nobel Prize awarded for mRNA technology used in the development of vaccines against COVID-19

Congratulations to Katalin Karikó and Drew Weissman who were jointly awarded the 2023 Nobel Prize in Physiology or Medicine for their work which led to the development of effective mRNA vaccines again...

Covid-19

Second medical uses at the EPO

The COVID-19 pandemic has highlighted the importance of investigating the use of known medications for the treatment of new diseases.

Covid-19

Counterfeit Christmas

Christmas is a counterfeiter’s high season, and with UK e-commerce expected to be worth almost GBP200 billion at the end of 2020 it is likely this year’s festive period will provide even more opportun...

Covid-19

How is COVID-19 changing patent practice?

We have all had to adapt in the past few months, as we have become used to widespread lockdowns, home working and reliance on technology rather than face-to-face contact.

Covid-19

AI in Drug Repurposing

To solve the greatest challenges, it often makes sense to turn to the most advanced technology. In healthcare, the present challenge has never been greater: how to combat the coronavirus pandemic.

Covid-19

The worldwide pharma response to coronavirus – Part 2: Promising leads

Rapid spread of the novel coronavirus, SARS-CoV-2, presents an enormous challenge for the global community.

Covid-19

How the engineering industry is aiding the fight against COVID-19

New technologies continually define and guide responses across the globe to the new challenges at hand. They ultimately save lives by enhancing our ability to harness resources in original and efficie...

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.

Connect with us